Literature DB >> 21435097

Hypoxia-inducible factor-1α polymorphisms are associated with genetic aberrations in lung cancer.

Andika C Putra1, Keiji Tanimoto, Marina Arifin, Keiko Hiyama.   

Abstract

BACKGROUND AND
OBJECTIVE: The transcription factor, hypoxia-inducible factor-1 (HIF-1), is a master regulator of hypoxia, including repression of DNA repair systems, resulting in genomic instability in cancer cells. The roles of the polymorphic HIF-1α variants, C1772T (P582S) and G1790A (A588T), which are known to enhance transcriptional activity, were evaluated in lung cancers.
METHODS: HIF-1α polymorphisms were assessed by direct sequencing in a total of 83 lung cancer patients (42 adenocarcinomas, 30 squamous cell, four adenosquamous cell and seven small cell lung carcinomas) and in 110 healthy control subjects. The relationship between these polymorphisms and the frequently observed genetic and/or epigenetic aberrations, TP53 loss of heterozygosity (LOH), 1p34 LOH, retinoblastoma-1 (RB1) LOH, p16 inactivation and epidermal growth factor receptor aberrations, was then assessed.
RESULTS: There were no significant differences in genotype frequencies for either C1772T or G1790A between lung cancer patients and healthy controls. However, the frequency of the HIF1A C1772T variant allele was significantly higher in lung cancer patients with TP53 LOH (P = 0.015). Among adenocarcinoma patients, individuals with variant alleles of either polymorphism showed significantly higher frequencies of TP53 LOH (P = 0.047), 1p34 LOH (P = 0.009), or either of these (P = 0.008) in the tumours. The in vitro transcriptional activity of these HIF1A variants in A549 lung cancer cells was significantly greater than that of the wild type under either normoxic or hypoxic conditions, especially for P582S in cells containing mutant p53 (P < 0.0005 and P < 0.005, respectively).
CONCLUSIONS: These findings indicate that functional polymorphisms in the HIF-1α gene may have an important impact on lung carcinogenesis, especially in adenocarcinomas, possibly by increasing genomic instability.
© 2011 The Authors; Respirology © 2011 Asian Pacific Society of Respirology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21435097     DOI: 10.1111/j.1440-1843.2011.01972.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  22 in total

Review 1.  The association between the rs11549465 polymorphism in the hif-1α gene and cancer risk: a meta-analysis.

Authors:  Yujie Li; Chunyan Li; Hui Shi; Lieming Lou; Pengcheng Liu
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 2.  HIF1A gene polymorphisms and human diseases: Graphical review of 97 association studies.

Authors:  I Gladek; J Ferdin; S Horvat; G A Calin; T Kunej
Journal:  Genes Chromosomes Cancer       Date:  2017-03-31       Impact factor: 5.006

Review 3.  The association between HIF-1α polymorphism and cancer risk: a systematic review and meta-analysis.

Authors:  Xin Hu; Yuan Fang; Jun Zheng; Yazhou He; Xin Zan; Sen Lin; Xi Li; Hao Li; Chao You
Journal:  Tumour Biol       Date:  2013-09-18

4.  High HIF-1α expression genotypes in oral lichen planus.

Authors:  Carlos Alberto de Carvalho Fraga; Lucas Rodrigues Alves; Luciano Marques-Silva; Adriana Alkmim de Sousa; Antonio Sérgio Barcala Jorge; Sabrina Ferreira de Jesus; Daniel Nogueira Vilela; Ugo Borges Pinheiro; Kimberly Marie Jones; Alfredo Maurício Batista de Paula; André Luiz Sena Guimarães
Journal:  Clin Oral Investig       Date:  2013-01-19       Impact factor: 3.573

5.  Hypoxia-inducible factor-1α (HIF-1α) C1772T polymorphism significantly contributes to the risk of malignancy from a meta-analysis.

Authors:  Gang Wu; Wen-Feng Yan; Yuan-Zeng Zhu; Pei-Chun Sun
Journal:  Tumour Biol       Date:  2014-01-15

6.  From tumor hypoxia to cancer progression: the implications of hypoxia-inducible factor-1 expression in cancers.

Authors:  Fariz Nurwidya; Fumiyuki Takahashi; Kunihiko Minakata; Akiko Murakami; Kazuhisa Takahashi
Journal:  Anat Cell Biol       Date:  2012-06-30

7.  The A Allele at rs13419896 of EPAS1 Is Associated with Enhanced Expression and Poor Prognosis for Non-Small Cell Lung Cancer.

Authors:  Andika C Putra; Hidetaka Eguchi; Kian Leong Lee; Yuko Yamane; Ewita Gustine; Takeshi Isobe; Masahiko Nishiyama; Keiko Hiyama; Lorenz Poellinger; Keiji Tanimoto
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

8.  An association study between hypoxia inducible factor-1alpha (HIF-1α) polymorphisms and osteonecrosis.

Authors:  Georgia Chachami; Alkmini Kalousi; Loukia Papatheodorou; Aggeliki Lyberopoulou; Vasileios Nasikas; Keiji Tanimoto; George Simos; Konstantinos N Malizos; Eleni Georgatsou
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

9.  The association between hypoxia-inducible factor-1 α gene C1772T polymorphism and cancer risk: a meta-analysis of 37 case-control studies.

Authors:  Pengfei He; Qi Han; Jiajia Liu; Dongjuan Liu; Xin Zhao; Ting Hu; Lu Jiang; Hongxia Dan; Xin Zeng; Jing Li; Jiayi Wang; Qianming Chen
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

10.  The association between hypoxia-inducible factor-1 α gene G1790A polymorphism and cancer risk: a meta-analysis of 28 case-control studies.

Authors:  Yuqiao Zhou; Lin Lin; Yun Wang; Xin Jin; Xin Zhao; Dongjuan Liu; Ting Hu; Lu Jiang; Hongxia Dan; Xin Zeng; Jing Li; Jiayi Wang; Qianming Chen
Journal:  Cancer Cell Int       Date:  2014-05-01       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.